Week 3: Anterior pituitary hormones, growth hormone Flashcards
1
Q
Actions of prolactin and regulation of release
A
- promotes milk secretion and maternal behavior, released by lactotrope cells
- stimulated by: suckling, TRH, moderate levels of estrogen
- inhibited by: dopamine (tonically inhibited by dopamine)
2
Q
regulation of LH and FSH release
A
- stimulatory: GnRH-gonadotropin releasing hormone
- inhibitory: negative feed back from estrogen and testosterone, prolactin
3
Q
Hyper and hypoprolactinemia
A
- hypoprolactinemia: from pituitary damage
- hyperprolactenemia: often from prolactinoma, most common pituitary tumor. Can lead to infertility, amenorrhea, galatorrhea, and hypogonadism in women. In men, can lead to impotence, infertility, increase in breast size.
- can treat prolactinoma with dopamine against such as bromocriptine to inhibit secretion.
4
Q
Effects of growth hormone
A
- GH is pulsatile. Can work directly or indirectly via insulin-like growth factor
1. Metabolism - prevents glucose utilization in muscles, adipose tissue, and other target tissues
- increases FFAs
- promotes amino acid uptake and protein synthesis
- overall: increases lean muscle mass, decreases adiposity, and is diabetogenic
2. Growth - promotes growth in size of limbs and internal organs
- linear growth at epiphyses
5
Q
Effects of IGF
A
- IGF-1 has profound effects on growth
- IGF-1 receptor has intrinsic tyrosine protein kinase activity
- insulin and IGFs probably work through different receptors.
- insulin increases the amount of IGF-1
6
Q
Regulation of GH secretion
A
- stimulatory
- hypoglycemia, insulin induced
- FFA decrease
- amino acid increase, particularly arginine
- estrogens
- GHRH
- fasting or prolonged caloric restriction
- exercise
- stage 4 sleep - inhibitory
- glucose increase
- FFA increase
- growth hormone, negative feedback
- somatostatin
- pregnancy
- obesity
7
Q
Growth hormone excess
A
- can cause giantism if before puberty and acromegaly after puberty
- can be treated with GH analog pegvisomant that lacks one binding site and prevents dimerization of GH receptor required for activation of receptor
8
Q
Laron syndrome
A
- children resistant to GH due to mutations in GH receptor
- use of IGF-1 to treat